Amid the pain of a pandemic, the world awaits vaccines and treatments, currently being pursued by a long list of medical researchers. Yet in a recent column in The New York Times, Bret Stephens ruefully observes that “one lesson from this pandemic is how dependent we are for our survival on an innovative and robust pharmaceutical industry. Maybe we should…